Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis
CA199 demonstrated only moderate diagnostic discrimination between PC and CP, with reduced efficacy in early-stage PC. Combining CA199 and eight exLRs exhibited promising differential diagnostic efficacy with both high sensitivity and specificity.
Authors
- Zhu Yp
- Yi Zheng (ORCID: https://orcid.org/0000-0002-9525-5609)
- Di Wu (ORCID: https://orcid.org/0000-0002-5775-8029)
- Zhimin Du (ORCID: https://orcid.org/0000-0001-7751-4219)
- Cao Yu
- Yanru Wang (ORCID: https://orcid.org/0000-0001-8272-2450)
- Lei Wang
- Hang-Ming Qi
- Zhuan Liao
- Wen-Bin Zou
Institutions
- Second Military Medical University (CN)
- Changhai Hospital (CN)
Publication Details
- Journal
- Translational Oncology
- Published
- 2026-01-16
- DOI
- https://doi.org/10.1016/j.tranon.2026.102674
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00